PACT (Patient Preferences in Adjuvant Colorectal Cancer Therapy) - A randomised crossover clinical trial comparing Bolus Fluorouracil/Leucovorin to Capecitabine as treatment for moderate to high risk ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-000686-19

PACT (Patient Preferences in Adjuvant Colorectal Cancer Therapy) - A randomised crossover clinical trial comparing Bolus Fluorouracil/Leucovorin to Capecitabine as treatment for moderate to high risk resected colorectal cancer

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary endpoint is patient preference for one of two regimens 12 weeks after randomisation, when the patient will have experienced both regimens


Critère d'inclusion

  • Moderate to high risk resected colorectal cancer

Liens